Another reason why prostate cancer may be “different” in African-American men

Posted on July 6, 2017 by Sitemaster

It has long been suspected that “intrinsic biological differences” play a role in why different racial groups appear to have different risk levels for prostate cancer incidence and mortality. … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , | Leave a comment »

Stopping metastasis before it even begins … Can we do that?

Posted on January 25, 2017 by Sitemaster

The idea that one could stop the initiation of prostate cancer metastasis before it even starts is fundamental to the idea that we might be able to eliminate prostate cancer as a cause of death. And it’s as true for prostate cancer as it is for nearly every other form of cancer. The problem is that we don’t yet know why prostate cancer metastasizes … and many suspect there may be more than one reason. … READ MORE …

Filed under: Drugs in development | Tagged: , , , , | 2 Comments »

Can specific miRNAs be used to predict risk of early biochemical relapse after first-line treatment?

Posted on August 8, 2011 by Sitemaster

No currently known biomarker can accurately predict the risk of prostate cancer recurrence at the time of or immediately following first-line treatment for localized prostate cancer. The best we can currently manage is to track a patient’s PSA level and his PSA doubling time. … READ MORE …

Filed under: Living with Prostate Cancer, Management | Tagged: , , , , | 3 Comments »